Response to Comment on: Butler et al. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? Diabetes Care 2013;36:2118–2125

Documenti analoghi

• Comment on: Butler et al. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 Therapies Safe? Diabetes Care 2013;36:2118–2125
  di: Bjerre Knudsen, Lotte, et al.
  Pubblicazione: (2013)
• A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?
  di: Butler, Peter C., et al.
  Pubblicazione: (2013)
• Comment on: Bernstein. Reducing Foot Wounds in Diabetes. Diabetes Care 2013;36:e48
  di: Morbach, Stephan, et al.
  Pubblicazione: (2013)
• Comment on Knowler et al. Preventing Diabetes in American Indian Communities. Diabetes Care 2013;36:1820–1822
  di: Jiang, Luohua, et al.
  Pubblicazione: (2014)
• Response to Comment on Knowler et al. Preventing Diabetes in American Indian Communities. Diabetes Care 2013;36:1820–1822
  di: Knowler, William C., et al.
  Pubblicazione: (2014)